logo
Hibiki Path Advisors Submits Shareholder Proposals for Tomoe Corporation's 93rd Annual General Meeting Scheduled for 27th June 2025

Hibiki Path Advisors Submits Shareholder Proposals for Tomoe Corporation's 93rd Annual General Meeting Scheduled for 27th June 2025

Yahoo26-05-2025
TOKYO, May 26, 2025--(BUSINESS WIRE)--Hibiki Path Aoba Fund (hereinafter referred to as "HPAF"), which has a discretionary investment contract with Hibiki Path Advisors (hereinafter referred to as "we", "our" or "Hibiki"), have submitted two shareholder proposals to be voted on at Tomoe Corporation (hereinafter referred to as "Tomoe")'s upcoming 93rd Annual General Meeting of Shareholders scheduled for 27th June 2025. The proposals are as follows:
Granting restricted stock compensation—up to 300 million yen per year (maximum of 251,000 shares)—to Directors (excluding Directors who are Audit & Supervisory Committee members and Outside Directors)
Adopting a shareholder return policy that ensures a dividend on equity (DOE) of 10% or more and a progressive dividend policy
Tomoe is a highly respected construction company specializing in complex three-dimensional structures. Developed in 1932, the company's signature "Diamond Truss" technology enables the creation of large, open architectural spaces without interior pillars and continue to be well-recognized across the industry for its superior engineering capabilities.
While the Company has an excellent business model, it faces the following issues:
Compensation structure for Directors: The combined shareholding of the Company's four Directors (excluding Audit & Supervisory Committee members and Outside Directors) amounts to approximately 200 million yen in market value, only 0.4% of the Company's market capitalization, which is extremely low. Furthermore, their compensation consists solely of fixed amount remuneration.
Financials: The Company holds approximately 35.4 billion yen in investment securities (primarily cross-shareholdings), accounting for around 30% of total assets and 50% of net assets. While "Mid-Term Management Plan (Japanese Only)" dated May 15, 2023, sets an ROE target of 10%, the ROE for FY3/25 based on NOPAT, which includes only profits derived purely from business operations, is just 3.8%.
* Stock price is based on the closing price of 1,324 yen on 19th May 2025. The number of shares held by directors is based on FY3/24 Annual Securities Report. The numbers for the investment securities and ROE are based on the FY3/25 Q4 Earnings Report. NOPAT is computed based on tax rate of 30%.
Above mentioned issues led (i) The Company's management team lacks a structure that would enable it to stand on the same footing as shareholders and focus on enhancing corporate value, As a result, (ii) the company's capital policy has not been properly addressed, and the P/B ratio has remained below 1x for many years and currently only 0.8x. In addition, the company owns real estate unrelated to its core business (with an unrealized pre-tax profit of approximately 40 billion yen), and the P/B ratio after adjustment for unrealized gains is 0.5x, which is extremely undervalued.
* Stock price is based on the closing price of 1,324 yen on 19th May 2025. Unrealized pre-tax profit on real estate is based on FY3/24 Annual Securities Report.
In "Measures to achieve management focused on cost of capital and stock price (Japanese Only)" dated 14th November 2024, Tomoe acknowledged that its net assets have been growing faster than its share price and recognized the need to address its overcapitalized balance sheet. However, despite the Company's recognition, no concrete actions have been taken. In consideration of this situation and to secure the common interests of all shareholders, we have decided to submit these proposals.
Please find the full shareholder proposal document at the following link:[Shareholder Proposal]
We respectfully ask our fellow shareholders to support our proposal from the perspective of enhancing and maximizing the common interests of all shareholders, and to exercise your voting rights proactively.
26th May 2025
Note: This post does not constitute a solicitation for an offer to acquire or recommend the purchase or sale of specific securities, or advice on investment, legal, tax, accounting, or any other matters. In the event of any discrepancy or conflict between the English and Japanese versions, unless otherwise noted, the meaning of the Japanese language version shall prevail unless otherwise expressly indicated.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250523781426/en/
Contacts
Yuya ShimizuRepresentative Director and Chief Investment OfficerHibiki Path Advisorswww.hibiki-path-advisors.com info@hibiki-path-advisors.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mizuho Raises Boston Scientific (BSX) Price Target as Robotics and Devices Drive Growth
Mizuho Raises Boston Scientific (BSX) Price Target as Robotics and Devices Drive Growth

Yahoo

time19 minutes ago

  • Yahoo

Mizuho Raises Boston Scientific (BSX) Price Target as Robotics and Devices Drive Growth

Boston Scientific Corporation (NYSE:BSX) ranks among the . Mizuho kept its Outperform rating on Boston Scientific Corporation (NYSE:BSX), and increased its price target for the medical device maker from $130 to $140 on July 24. The firm reported that the global recall of the ACURATE transcatheter aortic valve replacement (TAVR) system in the second half of the year was expected to be compensated by solid performance in Boston Scientific's FARAPULSE and WATCHMAN product lines. While Boston Scientific Corporation (NYSE:BSX) has no plans to re-engineer the ACURATE valve, putting it 'at square one in the TAVR space,' the company is still on track to acquire clearances for FARAPULSE in China and Japan before the end of the year, according to Mizuho's research. Boston Scientific Corporation (NYSE:BSX) is a global leader in the manufacture of medical devices, including stents, brain stimulation systems, heart monitors, and catheters. A leading name in robotics, the company has made great strides in the humanoid aspect of the industry with its two-legged Atlas robot. While we acknowledge the potential of BSX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BSX and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Richtech Robotics (RR) Expands in China With $4 Million Sales Agreement
Richtech Robotics (RR) Expands in China With $4 Million Sales Agreement

Yahoo

time19 minutes ago

  • Yahoo

Richtech Robotics (RR) Expands in China With $4 Million Sales Agreement

Richtech Robotics Inc. (NASDAQ:RR) ranks among the . Through its Chinese joint venture, Richtech Robotics Inc. (NASDAQ:RR) reported at the end of June that it had reached a sales agreement with Beijing Tongchuang Technology Development Co., Ltd. worth more than $4 million. possessed-photography-jIBMSMs4_kA-unsplash The contract covers the acquisition, maintenance, and software licensing of products from Richtech's ADAM, Scorpion, and Titan product lines. With analysts forecasting 33% rise in revenues for the fiscal year, the purchase is anticipated to boost the company's fourth-quarter revenue and create recurring revenue moving forward. According to a press release from the company, the new collaboration increases Richtech Robotics' footprint in China and could lead to new prospects throughout the Asian market. Richtech Robotics Inc. (NASDAQ:RR) specializes in interactive robotic solutions for the service sector, with additional applications in the healthcare and hotel industries. While we acknowledge the potential of RR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than RR and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Data Demystified Summit Bangkok, 7 October 2025 @ Hotel Nikko
Data Demystified Summit Bangkok, 7 October 2025 @ Hotel Nikko

Yahoo

time19 minutes ago

  • Yahoo

Data Demystified Summit Bangkok, 7 October 2025 @ Hotel Nikko

BANGKOK, Aug. 21, 2025 /PRNewswire/ -- We're proud to bring the Data Demystified Summit to one of Asia's most energetic and rapidly growing digital capitals – Bangkok. On 7 October 2025, data and tech leaders from across the region will converge at the Fuji Grand Ballroom, Hotel Nikko Bangkok, for a powerful one-day experience focused on simplifying data complexity in today's evolving business landscape. Co-located with The MarTech Summit, this English-speaking summit offers double the value: access to two communities and an exceptional platform for both insight and interaction. Whether you work in data governance, analytics, privacy, or consumer intelligence – this summit is for you. Secure your passes and elevate your tickets now: Why Attend Data Demystified Summit Bangkok? Bangkok's growing ecosystem of digital-first enterprises and regional headquarters makes it the perfect host city for our APAC edition. In 2025, the summit is laser-focused on execution—from frameworks to privacy strategies, from consumer data platforms to monetisation models. This edition will spotlight data strategies built for consumer brands and service-focused industries across Thailand's key sectors: manufacturing, tourism, hospitality, digital economy, healthcare, construction, and more. Attendees will gain access to: Regionally relevant insights from companies like foodpanda and LINE Behind-the-scenes sessions with Data Protection Officers, privacy lawyers, and compliance leads Dynamic formats: Panel Discussions, Lightning Talks, Fireside Chats, and more Cross-industry perspectives from retail, e-commerce, banking, insurance, and hospitality Access to a shared networking drinks reception with The MarTech Summit audience A new execution-focused agenda—where you'll walk away with real frameworks, not just theory Check out more detail: A Deep Dive Into What Matters Most Designed with real business use cases at heart, the Bangkok agenda dives into: Customer Data: From Collection to Consent CDPs, BI & Automation Privacy-First Data Governance Data Monetisation & AI Integration Business Intelligence for Brand Growth Expect over 25 speakers from top organisations and a delegate list packed with senior-level decision makers. Featuring a mix of Panel Discussions, Keynotes, Fireside Chats, and Lightning Talks, this summit delivers a dynamic, well-rounded experience. Check out the Speaker Line-up her: Two Powerful Summits, One Convenient Day The Data Demystified Summit Bangkok will be held alongside The MarTech Summit Bangkok at the same venue on 7 October 2025! Maximise your organisation's learning potential with our exclusive Dual Summit Pass, which allows free movement between both summits and access to all sessions. This summit is a must-attend for data scientists, analysts, engineering professionals, IT leaders, and business executives looking to unlock the full potential of their data resources. Don't miss out on the opportunity to stay ahead in the data revolution. Let's demystify data together! Secure your passes now: Check Out The MarTech Summit Bangkok PR Newswire is the official media partner of the Data Demystified Summit Bangkok 2025. Media Contact: Tiffany Nguyentnguyen@ View original content to download multimedia: SOURCE Data Demystified Summit 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store